Results 181 to 190 of about 284,051 (203)
Some of the next articles are maybe not open access.
The American Journal of Cardiology, 1993
Heterozygous familial hypercholesterolemia (FH) is completely expressed at birth and early in childhood by significant elevations in plasma total and low density lipoprotein (LDL) cholesterol levels. High density lipoprotein cholesterol can be low in such FH children; the triglyceride levels are usually within the normal range.
openaire +2 more sources
Heterozygous familial hypercholesterolemia (FH) is completely expressed at birth and early in childhood by significant elevations in plasma total and low density lipoprotein (LDL) cholesterol levels. High density lipoprotein cholesterol can be low in such FH children; the triglyceride levels are usually within the normal range.
openaire +2 more sources
Skin manifestations in familial heterozygous hypercholesterolemia:
2009Familial hypercholesterolemia, a form of primary hyperlipoproteinemia, is an autosomal dominant disorder characterized by an increase in serum LDL cholesterol concentrations. Multiple types of xanthomas occur, such as tendinous, tuberous, subperiosteal, and xanthelasma.
Pietroleonardo, Lucia, Ruzicka, Thomas
openaire +1 more source
Unveiling Compound Heterozygous Familial Hypercholesterolemia
Journal of Clinical Lipidology, 2022Daniel Soffer, Sohil Golwala
openaire +1 more source
iPhone apps for heterozygous familial hypercholesterolemia
Journal of Clinical Lipidology, 2013Ian G, Thomas +2 more
openaire +2 more sources
Portacaval shunt for familial heterozygous hypercholesterolemia.
Surgery, gynecology & obstetrics, 1981Two patients with heterozygous familial type 2 hypercholesterolemia are reported upon following treatment with end-to-side portacaval shunting. In both, the portacaval shunt decreased the cholesterol level by about 40 per cent. No adverse effects of the operation could be seen in either patient at 30 months, and no return of cardiovascular disease is ...
openaire +1 more source
Heterozygous familial hypercholesterolemia in the clinical management
Atherosclerosis, 2023N.T. Kim +5 more
openaire +1 more source
Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia
Circulation, 2012Evan Stein +2 more
exaly